Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gianfranco Pesce, MD
Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni
Study Chair - Roger Stupp, MD
Centre Hospitalier Universitaire Vaudois
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Oncology Institute of Southern Switzerland
Bellinzona, Switzerland
- Kantonsspital Graubuenden
Chur, Switzerland
- Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2005
- Primary completion
- 30 Apr 2009
- Completion
- 30 Nov 2010
- Last update posted
- 5 Jun 2012
- Registered enrollment
- 59
- Registry id
- NCT00238251
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.